First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Clinical trial NCT03625037 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03625037
Sponsor: Genmab
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

DLBCL High-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)FL MCL Small Lymphocytic Lymphoma (SLL)Marginal Zone Lymphoma (MZL)Indolent B-cell Non-Hodgkin Lymphoma (iNHL)Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)

Start date: 2018-06-26
Primary completion: 2029-01-01
Enrollment: 666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.